Print

Print


We have a patron who is trying to find out the status of FK-506.  According to
MDA Pipeline (1992) it was in phase III trials and probably approved in
1993.
 
The manufacturer (Fujisawa Pharm. a subsidiary of Lyphomed) doesn't seem
to be answering the question.
 
The drug is also called tacrolimus and there are a couple of variant spellings
 
 
of the trade name:  prograf or progref.
 
Thanks for any help.
 
JoAnne Sparks
Hahnemann University Library
[log in to unmask]
 
(215) 762-3696